Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05247788 · ClinicalTrials.gov registry record · NA

Impaired Risk Awareness During Intoxication in DUI Offenders

A NA study of Alcohol Use, sponsored by Mark Fillmore.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT05247788 is a NA study of Alcohol Use that has completed, run by Mark Fillmore. The registered enrollment target is 112 participants, below the 266-participant average among 23 other Alcohol Use trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05247788, a NA study of Alcohol Use, has completed, sponsored by Mark Fillmore.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the efficacy of experiential-based training to increase DUI offenders' perceptions or risk associated with alcohol use.

Conditions Studied

Interventions

  • BEHAVIORAL Blood alcohol concentration (BAC) discrimination training
  • BEHAVIORAL Performance feedback training
  • BEHAVIORAL Blood alcohol concentration (BAC) discrimination training for controls

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2022-02-02
Est. Completion 2025-03-01
Phase NA

Sponsor

Mark Fillmore

3 total trials

What the Registry Record Tells You About NCT05247788

The ClinicalTrials.gov registry entry for NCT05247788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 23 other Alcohol Use trials with a reported enrollment target (58% lower). The listed sponsor is Mark Fillmore, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use appearing as the primary indexed condition, and to 3 interventions - of which Blood alcohol concentration (BAC) discrimination training is the first listed.

NCT05247788 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05247788 about?

NCT05247788 is a clinical study titled "Impaired Risk Awareness During Intoxication in DUI Offenders". This study aims to test the efficacy of experiential-based training to increase DUI offenders' perceptions or risk associated with alcohol use.

What is the current status of trial NCT05247788?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2022-02-02. Estimated completion is 2025-03-01.

What conditions does trial NCT05247788 study?

This clinical trial studies the following conditions: Alcohol Use.

What interventions are being tested in trial NCT05247788?

The interventions under investigation include: Blood alcohol concentration (BAC) discrimination training (BEHAVIORAL), Performance feedback training (BEHAVIORAL), Blood alcohol concentration (BAC) discrimination training for controls (BEHAVIORAL).

Who is sponsoring clinical trial NCT05247788?

This trial is sponsored by Mark Fillmore, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05247788 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.